PharmStockPharmacy Stock

Mikacin Injection
Mikacin Injection

6.87
A generic medicine indicated for bacterial infections. Addresses bacterial growth by inhibiting essential protein synthesis required for microorganism survival.
Ingredient
Amikacin
Category
Antibiotics
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Amikacin sulfate
Reference Brand
Amikacin
Product Origin
Generic Brand
Product Manufacturer
Aristo Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antibiotics
Product Category
Aminoglycoside Antibiotic
Pharmacological Class
Protein Synthesis Inhibitor
Manufacturer Description
Developed to mitigate complex gram-negative infections to support rapid blood clearing and target bacterial replication.
Mechanism of Action
Binds to the 30S ribosomal subunit of susceptible bacteria, causing code translation errors that halt protein synthesis.
Route of Administration
Intravenous
Onset Time
30 minutes
Duration
12 hours
Contraindications
History of aminoglycoside-induced ototoxicity, Severe hypersensitivity to amikacin
Severe Adverse Events
Severe nephrotoxicity — requires immediate medical attention, Permanent ototoxicity — requires immediate medical attention, Neuromuscular blockade — requires immediate medical attention
Common Side Effects
Nausea, Headache, Vomiting
Uncommon Side Effects
Mild proteinuria, Vestibular dysfunction, Rash
Drug Interactions
Furosemide, Amphotericin B, Vancomycin
Pregnancy Safety Warnings
TGA Category D: High risk of congenital deafness in fetus. Avoid unless essential. Breastfeeding: Compatible.
Age Restrictions
Approved for infants, children, and adults.
Storage Guidelines
Store below 25°C.
Information related to Mikacin Injection is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Type 2 Diabetes Tablets - Dapagliflozin SGLT2 Inhibitor Diabetes